|
US1786412A
(en)
*
|
1929-11-20 |
1930-12-23 |
American Telephone & Telegraph |
Shielding arrangement
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US6024983A
(en)
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
|
WO1989001973A2
(en)
|
1987-09-02 |
1989-03-09 |
Applied Biotechnology, Inc. |
Recombinant pox virus for immunization against tumor-associated antigens
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
EP1645635A3
(en)
|
1989-08-18 |
2010-07-07 |
Oxford Biomedica (UK) Limited |
Replication defective recombinant retroviruses expressing a palliative
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
|
WO1991012325A1
(en)
|
1990-02-09 |
1991-08-22 |
E.I. Du Pont De Nemours And Company |
Htlv envelope antigenic segment
|
|
US5466468A
(en)
|
1990-04-03 |
1995-11-14 |
Ciba-Geigy Corporation |
Parenterally administrable liposome formulation comprising synthetic lipids
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
EP0598816B1
(en)
|
1991-08-15 |
1999-06-23 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines
|
|
US5756353A
(en)
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
|
DE69312487T2
(de)
|
1992-05-18 |
1997-11-27 |
Minnesota Mining & Mfg |
Einrichtung zur transmucosalen wirkstoffabgabe
|
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
|
WO1994015635A1
(en)
|
1993-01-11 |
1994-07-21 |
Dana-Farber Cancer Institute |
Inducing cytotoxic t lymphocyte responses
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
US5551622A
(en)
|
1994-07-13 |
1996-09-03 |
Yoon; Inbae |
Surgical stapler
|
|
AT402926B
(de)
|
1994-12-05 |
1997-09-25 |
Hafslund Nycomed Pharma |
Heterocyclische amide, verfahren zu ihrer herstellung und verwendung
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5580579A
(en)
|
1995-02-15 |
1996-12-03 |
Nano Systems L.L.C. |
Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
EP0832282A1
(en)
|
1995-06-02 |
1998-04-01 |
Incyte Pharmaceuticals, Inc. |
IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
DK1398379T3
(da)
|
1995-09-01 |
2007-01-08 |
Corixa Corp |
Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose
|
|
US6290969B1
(en)
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6338852B1
(en)
|
1995-09-01 |
2002-01-15 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6592877B1
(en)
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
ES2378051T3
(es)
|
1995-09-01 |
2012-04-04 |
Corixa Corporation |
Compuestos y métodos para el diagnóstico de la tubercolosis.
|
|
WO1997024447A1
(en)
|
1996-01-02 |
1997-07-10 |
Chiron Corporation |
Immunostimulation mediated by gene-modified dendritic cells
|
|
IL129389A0
(en)
|
1996-10-11 |
2000-02-17 |
Corixa Corp |
Compounds and methods for diagnsosis of tuberculosis
|
|
US6350456B1
(en)
|
1997-03-13 |
2002-02-26 |
Corixa Corporation |
Compositions and methods for the prevention and treatment of M. tuberculosis infection
|
|
US6627198B2
(en)
|
1997-03-13 |
2003-09-30 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis antigens and their uses
|
|
US6544522B1
(en)
|
1998-12-30 |
2003-04-08 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
US6613881B1
(en)
|
1997-05-20 |
2003-09-02 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
|
|
US6555653B2
(en)
|
1997-05-20 |
2003-04-29 |
Corixa Corporation |
Compounds for diagnosis of tuberculosis and methods for their use
|
|
DE69942214D1
(de)
|
1998-02-05 |
2010-05-12 |
Glaxosmithkline Biolog Sa |
Verfahren zur Reinigung oder Herstellung der MAGE Protein
|
|
WO1999051748A2
(en)
|
1998-04-07 |
1999-10-14 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
CZ301212B6
(cs)
|
1998-10-16 |
2009-12-09 |
Smithkline Beecham Biologicals S. A. |
Vakcinacní prostredek
|
|
JP2003510370A
(ja)
*
|
1999-10-07 |
2003-03-18 |
コリクサ コーポレイション |
Ｍｙｃｏｂａｃｔｅｒｉｕｍｔｕｂｅｒｃｕｌｏｓｉｓの融合タンパク質
|
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
AU6867801A
(en)
*
|
2000-06-20 |
2002-01-02 |
Corixa Corp |
Fusion proteins of mycobacterium tuberculosis
|
|
CN1277843C
(zh)
|
2001-02-22 |
2006-10-04 |
巴斯德研究院 |
分枝杆菌比较基因组学作为鉴定分枝杆菌病的诊断、预防或治疗靶的工具
|
|
AU2002303135A1
(en)
*
|
2001-03-13 |
2002-09-24 |
Corixa Corporation |
Heterologous fusion protein constructs comprising a leishmania antigen
|
|
WO2003072633A1
(en)
|
2002-02-14 |
2003-09-04 |
Mitsui Chemicals, Inc. |
Polyester resin and catalyst for polyester production, process for producing polyester resin with the catalyst, polyester resin obtained with the catalyst, and hollow molded container comprising the polyester resin
|
|
WO2003070187A2
(en)
|
2002-02-15 |
2003-08-28 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
US20060147477A1
(en)
*
|
2002-06-11 |
2006-07-06 |
Glaxo Group Limited |
Immunogenic compositions
|
|
US7205259B2
(en)
|
2002-07-26 |
2007-04-17 |
Kimberly-Clark Worldwide, Inc. |
Absorbent binder desiccant composition and articles incorporating it
|
|
GB0323965D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
EP1846931A1
(en)
|
2005-01-19 |
2007-10-24 |
Panduit Corporation |
Communication channels with suppression cores
|
|
PL2457926T3
(pl)
|
2005-04-29 |
2015-03-31 |
Glaxosmithkline Biologicals Sa |
Nowy sposób profilaktyki lub leczenia zakażenia m. tuberculosis
|
|
CA2606962A1
(en)
*
|
2005-04-29 |
2006-11-09 |
Fusion Antibodies Limited |
Assays for diagnosis of tuberculosis and uses thereof
|
|
EP2913403A1
(en)
|
2005-05-03 |
2015-09-02 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Importation of mitochondrial protein by an enhanced allotopic approach
|
|
JP4468858B2
(ja)
|
2005-06-01 |
2010-05-26 |
オリンパスイメージング株式会社 |
データ符号化装置、データ符号化方法、プログラム
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
US7296798B2
(en)
|
2006-01-31 |
2007-11-20 |
Matt Overfield |
Gameboard, games played on board and methods of play requiring strategy and luck
|
|
WO2008007942A1
(en)
*
|
2006-07-10 |
2008-01-17 |
Het Nederlands Kanker Instituut |
Means and methods for manipulating sequential phagolysomal-cytosolic translocation of mycobacteria, and uses thereof
|
|
CN101522218B
(zh)
|
2006-10-12 |
2012-09-26 |
葛兰素史密丝克莱恩生物有限公司 |
包含水包油乳液佐剂的疫苗
|
|
EP2368568A1
(en)
*
|
2006-11-01 |
2011-09-28 |
Immport Therapeutics, INC. |
Compositions and methods for immunodominant antigens
|
|
GB0622282D0
(en)
*
|
2006-11-08 |
2006-12-20 |
Novartis Ag |
Quality control methods
|
|
HUE031411T2
(en)
*
|
2007-03-02 |
2017-07-28 |
Glaxosmithkline Biologicals Sa |
New Methods and Preparations
|
|
GB0716070D0
(en)
*
|
2007-08-17 |
2007-09-26 |
Fusion Antibodies Ltd |
Diagnostic method and kit
|
|
US7670609B2
(en)
*
|
2007-11-27 |
2010-03-02 |
Aeras Global Tb Vaccine Foundation |
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
|
|
FR2933552B1
(fr)
|
2008-07-04 |
2014-10-10 |
Centre Nat Rech Scient |
Circuit d'amplification d'un signal representant une variation de resistance d'une resistance variable et capteur correspondant
|
|
UA107330C2
(uk)
*
|
2008-07-25 |
2014-12-25 |
Глаксосмітклайн Байолоджікалз С.А. |
Туберкульозний білок rv3616c та його застосування
|
|
CN102413837B
(zh)
|
2009-04-24 |
2015-11-25 |
国立血清研究所 |
预防再激活的结核病tb疫苗
|
|
US8567987B2
(en)
|
2009-07-21 |
2013-10-29 |
Cooper Technologies Company |
Interfacing a light emitting diode (LED) module to a heat sink assembly, a light reflector and electrical circuits
|
|
PL2528621T3
(pl)
*
|
2010-01-27 |
2017-07-31 |
Glaxosmithkline Biologicals S.A. |
Zmodyfikowane antygeny gruźlicy
|
|
US9119754B2
(en)
|
2011-10-08 |
2015-09-01 |
Michael Dennis |
Mattress overlay system with positionally adjustable, lateral ramp-wedge bolster structure
|
|
US9051890B2
(en)
|
2013-10-28 |
2015-06-09 |
Ford Global Technologies, Llc |
Method for estimating charge air cooler condensation storage with an intake oxygen sensor
|
|
US9903268B2
(en)
|
2015-04-02 |
2018-02-27 |
Ford Global Technologies, Llc |
Internal combustion engine with two-stage supercharging capability and with exhaust-gas aftertreatment arrangement, and method for operating an internal combustion engine
|
|
US9810514B2
(en)
|
2015-09-08 |
2017-11-07 |
Deufol Sunman Inc. |
Ammunition carrier consumer package
|